Skip to main content
Medical information Clinical review pending

Infection Testing

Fungal Multiplex Detection and Differentiation for Cryptococcus, Stachybotrys, Histoplasma RNA Detection Qualitative Test

This test identifies and differentiates RNA from Cryptococcus, Stachybotrys, and Histoplasma fungi using Real Time PCR technology. It helps diagnose fungal infections, especially in immunocompromised individuals or those with relevant symptoms.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood, Bronchoalveolar lavage (BAL) fluid, fresh tissue biopsy specimens, cerebrospinal fluid (CSF), or other relevant clinical samples. Confirm specific requirements with the laboratory before booking.
Results
Results are typically available within 4 working days via email or 36 hours via phone. Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required. However, inform the laboratory about any current medications or relevant medical history. Follow any specific instructions provided by your doctor or the collection center.
Test priceKSh 25,500

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Fungal Multiplex Detection and Differentiation for Cryptococcus, Stachybotrys, Histoplasma RNA Detection Qualitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspected fungal infection
  • ✓Symptoms such as persistent cough, skin lesions, or unexplained fever
  • ✓Immunocompromised patients
  • ✓Exposure history to relevant fungal environments
  • ✓Monitoring treatment effectiveness
  • ✓Diagnosis of Cryptococcosis
  • ✓Diagnosis of Stachybotryotoxicosis
  • ✓Diagnosis of Histoplasmosis
02

In plain language

What this test helps you understand

This test aids in the accurate identification of specific fungal infections (Cryptococcus, Stachybotrys, Histoplasma) by detecting their RNA. It helps clinicians differentiate between these pathogens, guiding appropriate antifungal therapy and patient management.
The Fungal Multiplex Detection and Differentiation Test is a diagnostic tool used to identify and distinguish between specific fungal pathogens: Cryptococcus, Stachybotrys, and Histoplasma. This test is particularly important for patients who may have fungal infections, enabling prompt and accurate diagnosis to guide appropriate treatment.

This test works by detecting the genetic material (RNA) of these fungi in a patient's sample. It uses Real Time PCR technology, which is known for its high sensitivity and specificity in identifying infections.

Individuals who might need this test include those with weakened immune systems, people experiencing symptoms like persistent cough, skin lesions, or unexplained fever, or those with a known exposure history to environments where these fungi are common.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required. However, inform the laboratory about any current medications or relevant medical history. Follow any specific instructions provided by your doctor or the collection center.
SampleBlood, Bronchoalveolar lavage (BAL) fluid, fresh tissue biopsy specimens, cerebrospinal fluid (CSF), or other relevant clinical samples. Confirm specific requirements with the laboratory before booking.
MethodologyReal Time Polymerase Chain Reaction (PCR) for RNA detection.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects RNA, indicating the presence of the fungal pathogen. It does not determine the viability of the fungus or the severity of the infection. Results must be interpreted in the context of the patient's clinical presentation and other diagnostic findings. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test detects the presence of RNA from Cryptococcus, Stachybotrys, and Histoplasma fungi in a patient sample.
Individuals with symptoms suggestive of fungal infection, those with weakened immune systems, or those with known exposure to these fungi may benefit from this test.
Samples can be collected from various sources like blood, BAL fluid, or tissue biopsies. Please consult the laboratory for specific requirements.
Results are typically provided via email within 4 working days or via phone within 36 hours. Confirm delivery method with the laboratory.
Generally, no specific preparation is needed, but inform the lab about your medical history and medications.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp